David Shaw’s BioNTech BNTX Stock Holding History

David Shaw’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,900	Closed	-$2.08M	–	4567
2025 Q4	$2.08M	Sell	21,900 -4,100	-16%	-$413K	﹤0.01%	3019
2025 Q3	$2.56M	Sell	26,000 -100	-0.4%	-$10.7K	﹤0.01%	2789
2025 Q2	$2.78M	Sell	26,100 -37,700	-59%	-$3.81M	﹤0.01%	2494
2025 Q1	$5.81M	Buy	63,800 +30,800	+93%	+$3.45M	0.01%	1772
2024 Q4	$3.76M	Sell	33,000 -10,000	-23%	-$1.14M	﹤0.01%	2214
2024 Q3	$5.11M	Buy	43,000 +20,900	+95%	+$1.92M	﹤0.01%	1925
2024 Q2	$1.78M	Buy	22,100 +4,100	+23%	+$375K	﹤0.01%	2756
2024 Q1	$1.66M	Buy	+18,000	New	+$1.73M	﹤0.01%	2768
2023 Q1	–	Sell	-35,000	Closed	-$5.26M	–	4458
2022 Q4	$5.26M	Hold	35,000	–	–	0.01%	2046
2022 Q3	$4.72M	Hold	35,000	–	–	0.01%	2162
2022 Q2	$5.22M	Sell	35,000 -40,000	-53%	-$6.11M	0.01%	2066
2022 Q1	$12.8M	Sell	75,000 -10,000	-12%	-$1.68M	0.01%	1380
2021 Q4	$21.9M	Buy	85,000 +30,000	+55%	+$8.22M	0.02%	1020
2021 Q3	$15M	Buy	55,000 +10,000	+22%	+$3.18M	0.01%	1213
2021 Q2	$10.1M	Buy	+45,000	New	+$8.49M	0.01%	1487

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

David Shaw's BNTX Position: Q2 2026 in Review

David Shaw increased its BioNTech (BNTX) stake by 109% in Q2 2026, buying an estimated $20.5M and bringing the position to 417,421 shares worth $38.8M. The position accounts for 0.02% of the portfolio, ranked #899.

David Shaw first reported a position in BNTX in Q4 2020 and has held it in 21 quarters since. The position peaked at $103M in Q1 2022. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

David Shaw held 417,421 shares of BioNTech worth $38.8M as of Q2 2026.
David Shaw bought 217,653 BioNTech shares in Q2 2026, an estimated $20.5M.
BioNTech made up 0.02% of David Shaw's portfolio in Q2 2026, its #899 holding.
David Shaw first reported a position in BioNTech in Q4 2020 and has held it in 21 quarters since.
David Shaw's BioNTech position peaked at $103M in Q1 2022.
281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.